Search Results for "Breast Pap Test Trial"

17:52 EDT 29th June 2016 | BioPortfolio

Matching Channels

Sniff test

Schilling test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps


At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

Medical News Today: Multi-gene test identifies early breast cancer that may be spared chemo

A multi-gene test that identifies early breast cancer patients who can be treated with anti-hormonal therapy alone and no chemotherapy has shown successful results in a trial.

Keytruda, talazoparib join I-SPY 2

QuantumLeap Healthcare Collaborative said it is adding two new treatment arms to the ongoing, adaptive Phase II I-SPY 2 trial, which is testing therapies to treat patients with hormone receptor (HR)-n...

'Ecologically diverse' breast cancers more likely to be deadly

(Institute of Cancer Research) Breast cancers which are particularly complex and diverse, as judged by a test used in ecology to analyze species of animals and plants, are particularly likely to progr...

Gene Test May Spare Some Breast Cancer Patients From Chemo

FRIDAY, March 11, 2016 -- A new genetic test seems to accurately identify women with early stage breast cancer who don't need chemotherapy, German researchers report. The test is called the 21-gene re...

Medical News Today: Novel test detects potentially harmful chemicals in breast milk

Researchers have created a test that they say can accurately detect the presence of bisphenol A and parabens - known endocrine-disrupting chemicals - in breast milk.

Spectrum Pharmaceuticals begins enrolling in SPI-2012 breast cancer trial

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations and a primary focus in hematology and oncology, has initiated the planned registratio...

Full dose radiotherapy to whole breast may not be needed in early breast cancer

(ECCO-the European CanCer Organisation) Five years after breast-conserving surgery, radiotherapy focused around the tumor bed is as good at preventing recurrence as irradiating the whole breast, with ...

‘Unprecedented’ breast cancer trial results explained

UK researchers running a clinical trial have presented some exciting preliminary results at a European breast cancer conference

Matching PubMed Articles

5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.

In a phase 3, randomised, non-inferiority trial, accelerated partial breast irradiation (APBI) for patients with stage 0, I, and IIA breast cancer who underwent breast-conserving treatment was compare...

Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.

IMPORT HIGH is a multi-centre randomised UK trial testing dose escalated intensity modulated radiotherapy after tumour excision in women with early breast cancer and higher than average local recurren...

Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer.

Accelerated partial breast irradiation (APBI) is emerging as an alternative to whole-breast irradiation. This study presents the results of a prospective trial evaluating 3-dimensional conformal radio...

Time for a randomised clinical trial evaluating breast conserving surgery compared to mastectomy in ipsilateral mutlifocal breast cancer (MFBC)?

Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients.

The ACOSOG Z0011 trial, a randomized controlled trial among patients with sentinel node positive breast cancer treated with breast conserving therapy, concluded that axillary lymph node dissection (AL...

Search Whole site using Google

Quick Search
Advertisement Advertisement